| 1 | BBIO | BridgeBio Pharma, Inc. | 7.42% |
| 2 | SLNO | Soleno Therapeutics, Inc. | 7.38% |
| 3 | TMDX | TransMedics Group, Inc. | 6.55% |
| 4 | RDNT | RadNet, Inc. | 6.20% |
| 5 | LIVN | LivaNova PLC | 6.19% |
| 6 | BPMC | Blueprint Medicines Corporation | 6.10% |
| 7 | MMSI | Merit Medical Systems, Inc. | 4.93% |
| 8 | COLL | Collegium Pharmaceutical, Inc. | 4.32% |
| 9 | TVTX | Travere Therapeutics, Inc. | 4.24% |
| 10 | ETNB | 89bio, Inc. | 4.08% |
| 11 | RARE | Ultragenyx Pharmaceutical Inc. | 4.03% |
| 12 | ATEC | Alphatec Holdings, Inc. | 3.98% |
| 13 | INSM | Insmed Incorporated | 3.64% |
| 14 | GH | Guardant Health, Inc. | 3.48% |
| 15 | MDGL | Madrigal Pharmaceuticals, Inc. | 3.15% |
| 16 | WVE | Wave Life Sciences Ltd. | 3.04% |
| 17 | KALV | KalVista Pharmaceuticals, Inc. | 2.91% |
| 18 | AKRO | Akero Therapeutics, Inc. | 2.86% |
| 19 | CORT | Corcept Therapeutics Incorporated | 2.32% |
| 20 | ACAD | ACADIA Pharmaceuticals Inc. | 1.97% |
| 21 | SYRE | Spyre Therapeutics, Inc. | 1.62% |
| 22 | UTHR | United Therapeutics Corporation | 1.56% |
| 23 | GMED | Globus Medical, Inc. | 1.52% |
| 24 | NVCR | NovoCure Limited | 1.08% |
| 25 | SVRA | Savara Inc. | 1.05% |
| View LFSC holdings |